V03AE03 • lanthanum • Various | All other therapeutic products | Drugs for treatment of hyperkalemia and hyperphosphatemia
Lanthanum is a chemical element used in medicine in the form of lanthanum carbonate for the treatment of hyperphosphatemia in patients with chronic kidney disease. It works by binding phosphates from food in the digestive tract, thereby reducing blood phosphorus levels.
The medication is taken orally, usually during meals, to maximize effectiveness. It is important for patients to follow a low-phosphorus diet during treatment.
Side effects may include nausea, diarrhea, constipation, or abdominal discomfort. In rare cases, allergic reactions or other complications may occur.
Patients should inform their doctor about any other medications they are taking, as drug interactions may occur. Pregnant or breastfeeding women should consult a specialist before use.
Substance: lanthanum
Date of last drug list: 01-10-2020
Commercial code: W66746003
Concentration: 500mg
Pharmaceutical form: chewable tablets
Quantity: 90
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: SHIRE PHARMACEUTICAL CONTRACTS LIMITED - MAREA BRITANIE
Holder: SHIRE PHARMACEUTICALS IRELAND LIMITED - IRLANDA
Number: 7353/2015/03
Shelf life: 3 years